The information on the Delegated Act on Safety Features for Medicinal Products for Human Use can be found here.
The form for the nomination of the representatives can be found here.
Medical Product Alert N°2/2026: Falsified JAKAVI (ruxolitinib) Falsified JAKAVI (ruxolitinib) identified in the WHO Eastern Mediterranean and European regions
The MMA Academy is developing a new course in advanced regulatory sciences for medicinal products — and this week is dedicated to listening to you. Take a moment to share your views and help shape a programme that reflects real training needs. Complete this ?? Form and tell us what matters most to you. #DesignedWithTheRegulatoryCommunity